XML 58 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events - Additional Information (Details)
$ / shares in Units, $ in Millions
1 Months Ended 6 Months Ended
Jul. 30, 2020
USD ($)
shares
Jul. 28, 2020
$ / shares
shares
Jul. 23, 2020
shares
Jul. 17, 2020
shares
Jul. 31, 2020
USD ($)
shares
Jun. 30, 2020
shares
Jul. 16, 2020
shares
Mar. 31, 2020
shares
Dec. 31, 2019
shares
Jun. 30, 2019
shares
Mar. 31, 2019
shares
Dec. 31, 2018
shares
Subsequent Event [Line Items]                        
Number of authorized shares of common stock           129,000,000     129,000,000      
Share based compensation options to purchase number of common stock           2,083,218     1,635,427     822,557
Convertible preferred stock, shares outstanding           95,982,862     72,416,431      
Number of common stock issued upon conversion           12,843,940     9,690,393      
Common Stock                        
Subsequent Event [Line Items]                        
Reverse stock split, description           one-for-7.4730            
2020 Stock Incentive Plan                        
Subsequent Event [Line Items]                        
Plan description           On July 17, 2020, the Company’s stockholders approved the 2020 Stock Incentive Plan (the “2020 Plan”), which became effective on July 23, 2020. The 2020 Plan provides for the grant of incentive stock options, nonstatutory stock options, stock appreciation rights, restricted stock awards, restricted stock units and other stock-based awards. The number of shares of the Company’s common stock reserved for issuance under the 2020 Plan is 1,588,315 shares; plus the shares of common stock remaining available for issuance under the 2017 Plan as of July 23, 2020. The number of shares reserved shall be annually increased on January 1, 2021 and each January 1 thereafter through January 1, 2030 by the lower of (i) 4% of the number of shares of common stock outstanding on the first day of such fiscal year and (ii) an amount determined by the Company’s board of directors. The shares of the Company’s common stock subject to outstanding awards under the 2017 Plan that expire, terminate or are otherwise surrendered, cancelled, forfeited or repurchased by the Company at their original issuance price pursuant to a contractual repurchase right will be added back to the shares of common stock available for issuance under the 2020 Plan. No more than 1,588,315 shares of the Company’s common stock may be granted subject to incentive stock options under the 2020 Plan.            
2020 Employee Stock Purchase Plan                        
Subsequent Event [Line Items]                        
Plan description           The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1, 2021 and each January 1 thereafter through January 1, 2031, in an amount equal to the lowest of (1) 397,079 shares of the Company’s common stock, (2) 1% of the number of shares of the Company’s common stock outstanding on the first day of such fiscal year and (3) an amount determined by the Company’s board of directors.            
Series A-2 Convertible Preferred Stock                        
Subsequent Event [Line Items]                        
Convertible preferred stock, shares outstanding           47,132,862   23,566,431 23,566,431 23,566,431 23,566,431 7,482,515
Number of common stock issued upon conversion           6,307,084     3,153,537      
Subsequent Event                        
Subsequent Event [Line Items]                        
Number of preferred stock authorized   5,000,000                    
Number of authorized shares of common stock   200,000,000   138,000,000     129,000,000          
Reverse stock split       0.1338                
Proceeds from issuance of shares | $ $ 116.5                      
Convertible preferred stock, shares outstanding   104,277,222                    
Number of common stock issued upon conversion   13,953,850                    
Subsequent Event | IPO                        
Subsequent Event [Line Items]                        
Shares issued   7,000,000                    
Shares issued, price per share | $ / shares   $ 16.00                    
Subsequent Event | Underwriters                        
Subsequent Event [Line Items]                        
Shares issued 1,050,000                      
Subsequent Event | Common Stock                        
Subsequent Event [Line Items]                        
Reverse stock split       0.1338                
Subsequent Event | 2020 Stock Incentive Plan                        
Subsequent Event [Line Items]                        
Common stock reserved for issuance     1,588,315                  
Number of common stock reserved for issuance increase percentage on stock outstanding     4.00%                  
Subsequent Event | 2020 Stock Incentive Plan | Maximum                        
Subsequent Event [Line Items]                        
Maximum common stock granted, under 2020 plan     1,588,315                  
Subsequent Event | 2020 Employee Stock Purchase Plan                        
Subsequent Event [Line Items]                        
Number of common stock reserved for issuance increase percentage on stock outstanding     1.00%                  
Share based compensation options to purchase number of common stock     198,539                  
Increase in additional number of shares to be issued     397,079                  
Subsequent Event | Series A-2 Convertible Preferred Stock                        
Subsequent Event [Line Items]                        
Number of preferred stock authorized       55,427,222     47,132,862          
Alexion Pharmaceuticals, Inc | Subsequent Event | Intellectual Property                        
Subsequent Event [Line Items]                        
Acquisition of intellectual property, estimated fair value | $         $ 17.8              
Alexion Pharmaceuticals, Inc | Subsequent Event | Series A-2 Convertible Preferred Stock                        
Subsequent Event [Line Items]                        
Preferred stock, issued         8,294,360